Tariffs Expose Cracks in U.S.–India Biotech Alliance, Chinese Analysts Say

For decades, the U.S. and India have appeared aligned in biotechnology. But Chinese commentators and policy analysts alike now point to a paradox: Trump’s new tariff plan, designed to push Indian drugmakers into relocating production to U.S. soil, adds fresh uncertainty and risk to what was supposed ...

China and Kenya Seal Pharma Deal

China and Kenya have reportedly signed a deal worth about $500 million to set up local vaccine and pharmaceutical production facilities using Chinese technology. Aden Duale, the Cabinet Secretary for Kenya’s Ministry of Health, said that the planned facilities would strengthen ...